CYTOSORBENTS CORPORATION Revenue by Geography
No Revenue by Geography for CTSO on this site yet.
- 2018-12-31: Others Not split by product in the filing$22.50M100.00%; Total revenue $22.50M.
- 2017-12-31: Others Not split by product in the filing$15.15M100.00%; Total revenue $15.15M.
- 2016-12-31: Others Not split by product in the filing$9.53M100.00%; Total revenue $9.53M.
- 2015-12-31: Others Not split by product in the filing$4.79M100.00%; Total revenue $4.79M.
Source checked: the stored Revenue by Geography page for CTSO.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2018-12-31 | Not split by product in the filing $22.50M 100.00% | $22.50M |
| 2017-12-31 | Not split by product in the filing $15.15M 100.00% | $15.15M |
| 2016-12-31 | Not split by product in the filing $9.53M 100.00% | $9.53M |
| 2015-12-31 | Not split by product in the filing $4.79M 100.00% | $4.79M |
| 2014-12-31 | Not split by product in the filing $4.12M 100.00% | $4.12M |
| 2013-12-31 | Not split by product in the filing $2.42M 100.00% | $2.42M |
| 2012-12-31 | Not split by product in the filing $1.34M 100.00% | $1.34M |
| 2011-12-31 | $36.08K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $9.63M 100.00% | $9.63M |
| 2025-06-30 | Not split by product $9.62M 100.00% | $9.62M |
| 2019-06-30 | Not split by product $6.23M 100.00% | $6.23M |
| 2019-03-31 | Not split by product $5.19M 100.00% | $5.19M |
| 2018-12-31 | Not split by product $6.08M 100.00% | $6.08M |
| 2018-09-30 | Not split by product $5.74M 100.00% | $5.74M |
| 2018-06-30 | Not split by product $5.76M 100.00% | $5.76M |
| 2018-03-31 | Not split by product $4.92M 100.00% | $4.92M |
| 2017-12-31 | Not split by product $4.65M 100.00% | $4.65M |
| 2017-09-30 | Not split by product $3.82M 100.00% | $3.82M |
| 2017-06-30 | Not split by product $3.57M 100.00% | $3.57M |
| 2017-03-31 | Not split by product $3.11M 100.00% | $3.11M |
| 2016-12-31 | Not split by product $3.08M 100.00% | $3.08M |
| 2016-09-30 | Not split by product $2.41M 100.00% | $2.41M |
| 2016-06-30 | Not split by product $2.22M 100.00% | $2.22M |
| 2016-03-31 | Not split by product $1.81M 100.00% | $1.81M |
| 2015-12-31 | Not split by product $1.76M 100.00% | $1.76M |
| 2015-09-30 | Not split by product $1.34M 100.00% | $1.34M |
| 2015-06-30 | Not split by product $963.94K 100.00% | $963.94K |
| 2015-03-31 | Not split by product $723.07K 100.00% | $723.07K |
| 2014-12-31 | Not split by product $873.66K 100.00% | $873.66K |
| 2014-09-30 | Not split by product $1.16M 100.00% | $1.16M |
| 2014-06-30 | Not split by product $1.02M 100.00% | $1.02M |
| 2014-03-31 | Not split by product $1.06M 100.00% | $1.06M |
| 2013-12-31 | Not split by product $879.16K 100.00% | $879.16K |
| 2013-09-30 | Not split by product $880.69K 100.00% | $880.69K |
| 2013-06-30 | Not split by product $291.48K 100.00% | $291.48K |
| 2013-03-31 | Not split by product $371.33K 100.00% | $371.33K |
| 2012-12-31 | Not split by product $604.32K 100.00% | $604.32K |
| 2012-09-30 | Not split by product $605.35K 100.00% | $605.35K |
| 2012-06-30 | Not split by product $33.04K 100.00% | $33.04K |
| 2012-03-31 | Not split by product $16.89K 100.00% | $16.89K |
| 2011-12-31 | Not split by product $36.08K 100.00% | $36.08K |
| 2011-09-30 | Not split by product $0.00 | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |